IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
https://doi.org/10.17709/2409-2231-2019-6-2-5
Abstract
Purpose of the study. To improve the quality of prostate transurethral resection by means of intraoperative ultrasound monitoring of the removed tissue volume.
Patients and methods. The study included 92 patients who, according to indications, underwent prostate transurethral resection. Patients were divided into 2 groups. The 1st group included patients (n = 50) operated on using the method of monitoring the removed tissue volume, proposed in the study. The average age of patients in this group was 67.4 ± 3.88 years, the average prostate volume before surgery was 59.5 ± 4.5 cm3 with a range of values from 42 cm3 to 94 cm3. The 2nd group (n = 42) included patients operated on according to the classical method of prostate transurethral resection. The average age of patients in this group was 68.1 ± 2.9 years, the average prostate volume before surgery was 53.5 ± 4.5 cm3.
Results. The average prostate volume atier surgery in patients of the 1st group was 23.2 ± 1.8 cm3. Thus, the average volume of the removed tissue was 63.2% of the prostate gland initial volume. The average prostate volume atier surgery in patients of the 2nd group was 25.6 ± 1.9 cm3 (p < 0.05). The average volume of the removed tissue was 52.1% of the prostate gland initial volume. The number of complications is comparable in groups of patients. When using the removed tissue control during surgery, it was possible to increase the resection radicality, which is refl ected by a smaller average residual volume of the prostate gland (by 9.4%) atier surgery.
Conclusion. The use of ultrasonic control of the prostate adenoma removed tissue volume during prostate transurethral resection does not increase the risks of possible postoperative complications, wherein increases radicality of the performed operation.
About the Authors
V. B. FilimonovRussian Federation
MD, PhD, DSc, head of the department of urology and nephrology
9 Vysokovol'tnaya str., Ryazan' 390026, Russian Federation
R. V. Vasin
Russian Federation
MD, PhD, associate professor at the department of urology and nephrology
9 Vysokovol'tnaya str., Ryazan' 390026, Russian Federation
I. S. Sobennikov
Russian Federation
MD, PhD, assistant of the department of urology and nephrology
9 Vysokovol'tnaya str., Ryazan' 390026, Russian Federation
References
1. Sevryukov FA, Kamaev IA, Grib MN, Perevezentsev EA, Malinina OY, Yelina JA. Risk factors and quality of life in pa ents with benign prosta c hyperplasia. I. P. Pavlov Russian Medical Biological Herald (Rossiyskiy mediko-biologicheskiy vestnik imeni akademika I. P. Pavlova). 2011;19 (3):48–52. (In Russian).
2. Djaparov J. T., Usupbaev A.Ch., Kylychbekov M. B., Kurmanbekov N. K. Benign prosta c hyperplasia combined with chronic calculous prosta s (Rewiev). Vestnik Kyrgyzsko-Rossiiskogo slavyanskogo universiteta. 2017;10 (17):26–8. (In Russian).
3. Kaprin AD, Kostin AA, Kulchenko NG. Optimization of drug therapy for benign prostatic hyperplasia. Vopr. urol. androl. (Urology and Andrology). 2013;2 (1):5–9. (In Russian).
4. Filimonov VB, Vasin RV, Sobennikov IS. Growth of an bio c resistance of microorganisms in pa ents with hyperplasia of prostate as a medical and social problem. Nauka molodykh (Erudi o Juvenium). 2019;7 (1):106–13. DOI: 10.23888/HMJ201971106– 112 (In Russian).
5. Gevorkyan RR, Semenov OV, Ivanov VYu, Malkhasyan VA, Semenyakin IV, Smbatyan VV, Pushkar DYu. Analysis of surgical care for pa ents with benign prosta c hyperplasia in the Republic of Crimea. Vopr. urol. androl. (Urology and Andrology). 2018;6 (4):5– 10. DOI: 10.20953/2307–6631–2018–4-5–10 (In Russian).
6. Alferov SM, Dobuzhinsky VA, Grishin MA. Bipolar transurethral resec on and plasma abla on of the prosthe c gland in old and elderly Research’n Practical Medicine Journal 2019, v.6, №2, p. 51-57
7. Bik mirov RG, Martov AG, Bik mirov TR, Marapov DI, Kaputovskij AA. Compara ve study of extraperitoneoscopic adenomectomy and monopolar transurethral resec on in surgical management of benign prosta c hyperplasia with prostate volume of 100–180 cm3. Urology. 2018;3:88–91. DOI: 10.18565/ urology.2018.2.88–91 (In Russian).
8. Popov SV, Orlov IN, Sushina IV, Vyazovtsev PV, Grin YeA, Malevich SM, Sytnik DA. Transurethral enuclea on of prostate adenoma and extraperitoneal endovideosurgical adenomectomy: postopera ve results and three-month observa on. Astrakhan Medical Journal. 2018;13 (3):51–9. (In Russian).
Review
For citations:
Filimonov V.B., Vasin R.V., Sobennikov I.S. IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME. Research and Practical Medicine Journal. 2019;6(2):51-57. (In Russ.) https://doi.org/10.17709/2409-2231-2019-6-2-5